Home›Companies›Healthcare›Opus Medical Therapies

Opus Medical Therapies, LLC

Develops catheter-delivered replacement heart valves for patients with valve disease.

No website or LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 22, 2026·Suggest an edit

About Opus Medical Therapies

Opus Medical Therapies is a private company based in Smyrna, Georgia. It has reported $5,233,230 raised in three offerings on Form D since August 2019.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 14, 2026Sep 22, 2026$485,089target not set4$121KEquityRule 506(b)Form D ↗
Sep 4, 2019Sep 4, 2020$1,748,141fully sold12$145KDebtRule 506(b)Form D ↗
May 4, 2018Aug 19, 2019$3,000,000fully sold31$96,774DebtRule 506(b)Form D ↗
Total, three offerings$5,233,230

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Opus Medical Therapies's Form D filed Sep 22, 2026.

VR
Vivek Rajagopal
Chief Medical Officer

Earlier filings also listed Yen Liao (director, last listed Sep 2020) and Jaime Sarabia (director, last listed Sep 2020).

Sources

  1. SECOpus Medical Therapies, LLC filing history
  2. PressVenus Medtech and Opus Medical Therapies partnership announcement